Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma. [electronic resource] by
- Mandic, Maja
- Castelli, Florence
- Janjic, Bratislav
- Almunia, Christine
- Andrade, Pedro
- Gillet, Daniel
- Brusic, Vladimir
- Kirkwood, John M
- Maillere, Bernard
- Zarour, Hassane M
Producer: 20050315
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 174
Availability: No items available.
|
|
16.
|
CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1. [electronic resource] by
- Fourcade, Julien
- Sun, Zhaojun
- Pagliano, Ornella
- Guillaume, Philippe
- Luescher, Immanuel F
- Sander, Cindy
- Kirkwood, John M
- Olive, Daniel
- Kuchroo, Vijay
- Zarour, Hassane M
Producer: 20120420
In:
Cancer research vol. 72
Availability: No items available.
|
|
17.
|
Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins. [electronic resource] by
- Castelli, Florence A
- Leleu, Mélanie
- Pouvelle-Moratille, Sandra
- Farci, Sandrine
- Zarour, Hassane M
- Andrieu, Muriel
- Auriault, Claude
- Ménez, André
- Georges, Bertrand
- Maillere, Bernard
Producer: 20070911
In:
European journal of immunology vol. 37
Availability: No items available.
|
|
18.
|
Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients. [electronic resource] by
- Kudela, Pavol
- Janjic, Bratislav
- Fourcade, Julien
- Castelli, Florence
- Andrade, Pedro
- Kirkwood, John M
- El-Hefnawy, Talal
- Amicosante, Massimo
- Maillere, Bernard
- Zarour, Hassane M
Producer: 20080205
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 179
Availability: No items available.
|
|
19.
|
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690. [electronic resource] by
- Kirkwood, John M
- Richards, Thomas
- Zarour, Hassane M
- Sosman, Jeffrey
- Ernstoff, Marc
- Whiteside, Theresa L
- Ibrahim, Joseph
- Blum, Ronald
- Wieand, Samuel
- Mascari, Ruth
Producer: 20020917
In:
Cancer vol. 95
Availability: No items available.
|
|
20.
|
|